The following case report follows a 78-year-old male with CLI who underwent invasive total ankle joint replacement.
This article seeks to evaluate the effectiveness of the Celt ACD (Vasorum, Ltd) for the closure of antegrade superficial femoral artery access to treat ipsilateral lower-extremity arterial lesions.
We present the successful treatment of critical hand ischemia in a young patient with end-stage renal disease using orbital atherectomy and balloon angioplasty.
Commentary on Khan A, Green DL, Santilli S, et al. Preoperative C-reactive protein levels predict readmission following elective vascular surgery. J Crit Limb Ischemia. 2022;2(2):E39-E44.
Commentary on Jammeh ML, Suggs J, Adams GL, et al. Outcomes of orbital atherectomy in patients with critical limb threatening ischemia and diabetes. J Crit Limb Isch. 2022;2(2):E29-E37. Epub 2022 Apr 12.
C-reactive protein levels may be reduced with long-term administration of ubiquinone (CoQ10) in patients with chronic ischemic heart disease, but the impact of a short-term period of administration in patients undergoing elective vascular surgery is uncertain.
Patients with diabetes and critical limb threatening ischemia (CLTI) are at significantly higher risk of limb loss and death. We evaluate the outcomes of orbital atherectomy (OA) for the treatment of CLTI in patients with and without diabetes.